ASH 2020: J&J/Legend’s Cilta-Cel Shines, But BMS/Bluebird’s Ide-Cel Is In First Place

Both BCMA-Targeting CAR-T Therapies Could Be Approved In 2021

 
• By Mandy Jackson
Multiple Myeloma Awareness: Bone marrow aspirate cytology of multiple myeloma, a type of bone marrow cancer of malignant plasma cells, associated with bone pain, bone fractures and anemia.
BCMA-targeting CAR-T therapies show durable responses in multiple myeloma • Source: Shutterstock

More from Clinical Trials

More from R&D